Abstract: An example of subject may deliver a therapy by delivering energy to tissue. The system may comprise a magnetic field system and an electric field system. The magnetic field system may be configured to provide a magnetic field in a first direction to the tissue. The magnetic field system may include at least one magnetic field source to produce the magnetic field. The magnetic field produced by the at least one magnetic field source may include a magnetic field produced by at least one of a permanent magnet, a temporary magnet or electric current flow through a conductor. The electric field system may be configured to provide an electric field in a second direction to the tissue. The electric field system may include at least one electric field source to provide the electric field and the second direction is non-parallel to the first direction.

Abstract: The Solid-State distinct-unidirectional photonic interferometer is an onboard opto-electronic navigational instrument that utilizes propagation of light within the instrument for continuously and independently, from other sources, detecting and measuring position, orientation, displacement, and rates of the displacement of an object in motion from within and from the motion itself.

Abstract: Various embodiments disclose a method performed by a first node device in a mesh network that includes identifying a plurality of neighbor node devices that have one or more blocks of a dataset; determining quality scores for respective node devices of the plurality of neighbor node devices; selecting, based on the quality scores, a second node device from the plurality of neighbor node devices; and sending, to the second node device, a first request to receive at least one block of the one or more blocks.

Abstract: A multiple-part curable composition, a cured composition formed by combining and reacting the multiple-part curable composition, and a method of providing a cured composition are described. The multiple-part curable composition contains at least a part A and a part B. Part A contains an oxalamido-containing compound while part B contains a derivatized polyethylene imine. The cured composition is an adhesive that is suitable for use as a tissue adhesive.

Abstract: A light source of a matrix arrangement of light sources of a motor vehicle lighting module includes a substrate having an upper face, a lower face opposite the upper face, and an electronic circuit. At least one light-emitting element is mounted on the upper face of the substrate and includes a light-emitting part. Also included is an optical device for forming the light beams emitted by the light-emitting element, and the lower face includes connection contacts connected to the electronic circuit, the electronic circuit being adapted to power the at least one light-emitting element. The light-emitting part of at least one light-emitting element having a surface area of less than 40,000 ?m2. The optical device includes an optical element that is produced by being molded onto the at least one light-emitting element and at least partially onto the upper face of the substrate.

Abstract: A vaporizer device includes various modular components. The vaporizer device includes a first subassembly. The first subassembly includes a cartridge connector that secures a vaporizer cartridge to the vaporizer device and includes at least two receptacle contacts that electrically communicate with the vaporizer cartridge. The vaporizer device includes a second subassembly. The second subassembly includes a skeleton defining a rigid tray that retains at least a power source. The vaporizer device also includes a third subassembly. The third subassembly includes a plurality of charging contacts that supply power to the power source, and an end cap that encloses an end of the vaporizer device.

Abstract: A method includes transferring multiple discrete components from a first substrate to a second substrate, including illuminating multiple regions on a top surface of a dynamic release layer, the dynamic release layer adhering the multiple discrete components to the first substrate, each of the irradiated regions being aligned with a corresponding one of the discrete components. The illuminating induces a plastic deformation in each of the irradiated regions of the dynamic release layer. The plastic deformation causes at least some of the discrete components to be concurrently released from the first substrate.

Abstract: A vector comprises a polynucleotide encoding an antibody or antibody fragment for use in a method of treatment of a disease or disorder of the central nervous system (CNS) in a subject, wherein the vector transduces or transfects cells of the blood brain barrier (BBB) and the transduced or transfected BBB cells express the antibody or antibody fragment resulting in delivery of the antibody or antibody fragment into the CNS, preferably into the brain parenchyma.

Abstract: A method includes positioning a discrete component assembly on a support fixture of a component transfer system, the discrete component assembly including a dynamic release tape including a flexible support layer, and a dynamic release structure disposed on the flexible support layer, and a discrete component adhered to the dynamic release tape. The method includes irradiating the dynamic release structure to release the discrete component from the dynamic release tape.

Abstract: A method including configuring a first server to receive, from a second server, an encrypted authentication packet to enable the first server and the second server to conduct an authentication process, the encrypted authentication packet including a crypted code field indicating that a portion of the encrypted authentication packet is encrypted and a crypted payload including an encrypted initial authentication packet; and configuring the first server to transmit, to the second server, a response based at least in part on determining that the portion of the encrypted authentication packet is encrypted and on decrypting the encrypted initial authentication packet. Various other aspects are contemplated.

Abstract: Provided are methods for increasing the yield of a monocot plant through treatment of the plant with a plant growth regulator. In certain embodiments, maize plants produce multiple ears and an increased number of kernels. In certain embodiments, reduced height of the plant allows for more efficient self-pollination.

Abstract: A method is provided for monitoring medical information using a portable medical device and a mobile device, comprising: establishing a communication link between the mobile device and a download server; selecting, depending on the type of mobile device, a communication software package from a plurality of communication software packages accessible by the download server; downloading the selected communication software package to the mobile device over the link; installing the communication software package on the mobile device; wirelessly transferring medical data from the portable medical device to the mobile device using the installed communication software package; and uploading at least a portion of the medical data from the mobile device to a medical care server.

Abstract: The present invention relates to a method of treatment for chronic pain, opioid dependence, alcohol use disorder or autism using a class of pyrimidinone compounds, an adenylyl cyclase 1 (AC1) inhibitor. The invention described herein also pertains to pharmaceutical compositions and methods for treating diseases in mammals using those compounds disclosed herein.

Abstract: The present invention provides HIV-1 vaccine immunogens. Some of the immunogens contain a soluble gp140-derived protein that harbors a modified N-terminus of the HR1 region in gp41. Some of the immunogens contain an HIV-1 Env-derived trimer protein that is presented on a nanoparticle platform. The invention also provides methods of using the HIV-1 vaccine immunogens for eliciting an immune response or treating HIV infections.

Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.

Abstract: Provided are methods for increasing the yield of a monocot plant through treatment of the plant with a plant growth regulator. In certain embodiments, maize plants produce multiple ears and an increased number of kernels. In certain embodiments, reduced height of the plant allows for more efficient self-pollination.

Abstract: Techniques for facilitating communication between an implantable medical device and an external device are provided. In one example, a method comprises broadcasting, via communication circuitry of an implantable device, a first set of advertisements at a first advertising rate according to a communication protocol. The method further comprises determining that detection circuitry of the implantable device detected voltage induced by an electromagnetic field at an interface between tissue of a patient and electrodes of the implantable device and in response to the detection of voltage induced by the electromagnetic field, broadcasting, via the communication circuitry, a second set of advertisements at a second advertising rate according to the communication protocol. The second advertising rate is greater than the first advertising rate.

Abstract: A system includes a current source circuit; a system power input; and load switching circuitry coupling the current source circuit and the system power input to an output configured to couple to a vaporizer heating element. The current source circuit, the system power input, and the load switching circuitry form part of an integrated circuit. Related apparatus, systems, techniques, and articles are also described.

Abstract: The present device and technique relates to measuring geological formation permeability, such as by injection/withdrawal of conductivity-permeability doped fluid and measuring the magnetic permeability and/or conductivity of the surrounding formation. Before, during and/or after injection or withdrawal, pluralities of electromagnetic measurements of the radial distribution of magnetic permeability and/or conductivity of the surrounding formation may be made. The rate of change of the radial distribution of magnetic permeability and/or conductivity of the formation is generally directly proportional to the permeability of the surrounding formation. In implementations, magnetic permeability and electrical conductivity can be measured independently in time domain or frequency domain, such that the magnetic permeability mapping is not disturbed by other confounding electromagnetic parameters.

Abstract: A light source a matrix arrangement of light sources of a motor vehicle lighting module includes a substrate having an upper face, a lower face opposite the upper face, and an electronic circuit. At least one light-emitting element is mounted on the upper face of the substrate and includes a light-emitting part. Also included is an optical device for forming the light beams emitted by the light-emitting element and the lower face includes connection contacts connected to the electronic circuit, the electronic circuit being adapted to power the at least one light-emitting element. The light-emitting part of at least one light-emitting element has a surface area of less than 40,000 ?m2, and the beam-forming optical device has an optical element on the upper face of the substrate and/or on the light-emitting part of the at least one light emitting element.